Malcolm K. Brenner
Houston Methodist · 872 works · 55,499 citations · h-index 117
Top works
- Transplantability and therapeutic effects of bone marrow-derived mesenchymal cells in children with osteogenesis imperfecta
- Use of gene-modified virus-specific T lymphocytes to control Epstein-Barr-virus-related lymphoproliferation
- Virus-specific T cells engineered to coexpress tumor-specific receptors: persistence and antitumor activity in individuals with neuroblastoma
- Infusion of Cytotoxic T Cells for the Prevention and Treatment of Epstein-Barr Virus–Induced Lymphoma in Allogeneic Transplant Recipients
- CD28 costimulation improves expansion and persistence of chimeric antigen receptor–modified T cells in lymphoma patients
- Evidence for Zanamivir Resistance in an Immunocompromised Child Infected with Influenza B Virus
- Gene-marking to trace origin of relapse after autologous bone-marrow transplantation
- Long–term restoration of immunity against Epstein–Barr virus infection by adoptive transfer of gene–modified virus–specific T lymphocytes
- A distinct “side population” of cells with high drug efflux capacity in human tumor cells
- Gene marking to determine whether autologous marrow infusion restores long-term haemopoiesis in cancer patients
- Inducible Apoptosis as a Safety Switch for Adoptive Cell Therapy
- Antitumor activity and long-term fate of chimeric antigen receptor–positive T cells in patients with neuroblastoma
- Clinical responses to bone marrow transplantation in children with severe osteogenesis imperfecta
- Direct demonstration that autologous bone marrow transplantation for solid tumors can return a multiplicity of tumorigenic cells
- Long-term outcome of EBV-specific T-cell infusions to prevent or treat EBV-related lymphoproliferative disease in transplant recipients
- TUMOUR NECROSIS FACTOR AS AN AUTOCRINE TUMOUR GROWTH FACTOR FOR CHRONIC B-CELL MALIGNANCIES
- Early identification of Epstein‐Barr virus‐associated post‐transplantation lymphoproliferative disease
- Human Epidermal Growth Factor Receptor 2 (HER2) –Specific Chimeric Antigen Receptor–Modified T Cells for the Immunotherapy of HER2-Positive Sarcoma
- A chimeric T cell antigen receptor that augments cytokine release and supports clonal expansion of primary human T cells
- Outcomes of transplantation with matched-sibling and unrelateddonor bone marrow in children with leukaemia